Dr. Jun Shoji, MD

Dr. Shoji practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Shoji's NPI, 1942524483, was assigned on March 25, 2010. Dr. Shoji graduated from George Washington University School of Medicine and Health Sciences in 2010. Dr. Shoji holds California license A136327.

Dr. Shoji's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Shoji's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Shoji to 3 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shoji practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Shoji's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Shoji is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Shoji's licenses on file in 4 states: California, Hawaii, District of Columbia and Virginia.

Dmand AI lists chronic anemia and fluid and electrolyte imbalances among the conditions Dr. Shoji treats.

CMS data shows 1,020 Medicare services from Dr. Shoji across 7 procedure codes in 2024, for 388 Medicare patients. Medicare paid $110,577 for them.

CMS counts 388 Medicare patients who saw Dr. Shoji in 2024. The largest group is under 65, with 228 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 63% are also on Medicaid. Their average risk score is 6.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shoji's median patient age at 58, with 37% women.

In 2024, Dr. Shoji wrote 3,081 Medicare Part D claims for 363 patients. 84% of them were for generic drugs. CMS names the drug for 2,704 of them, across 41 drugs with 11 or more claims each, at $196,208 in total drug cost. In 2023, CMS named 1,744 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Shoji for performance year 2024, reported as part of a group. Dr. Shoji accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shoji as offering telehealth.

Dmand AI links 17 papers to Dr. Shoji, published from 2013 to 2024. 2024 was the busiest year, with 3. The most frequent topics are Glomerulosclerosis, Focal Segmental, Kidney Failure, Chronic and Biopsy. Dr. Shoji has published most often in Transplantation. Dr. Shoji's most frequent co-authors are Chris E. Freise, MD, James Morgan Gardner, MD, PhD and Alan S. Go, MD.

CMS Open Payments shows 57 general payments to Dr. Shoji from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 52% of the total. Pfizer Inc. paid the most, $2,350.

Dr. Shoji graduated from George Washington University School of Medicine and Health Sciences in 2010.

Dr. Shoji is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.